VEGFA and ovarian cancer: Multiple logistic regression analysis identified 4 independent predictors of PARPi-associated SHAEs in patients with ovarian cancer: lymph node metastasis (odds ratio [OR] 6.733, 95% CI 1.197-37.873; P=.03), creatinine clearance rate of ≤60 mL per minute (OR 23.722, 95% CI 3.121-180.303; P=.002), RBC count of ≤3.3×1012 per liter (OR 4.847, 95% CI 1.020-23.041; P=.047), and combination therapy with vascular endothelial growth factor inhibitors (OR 6.749, 95% CI 1.313-34.689; P=.02).